Prosecution Insights
Prosecution Insights
5 pending office actions • 1 client • 4 examiners • 3 art units • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (20%) |
| §112 only | 3 (60%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUYNH, PHUONG N | 2 | 65.7% | +53.7% |
| JACKSON, SHAWQUIA | 1 | 78.0% | -3.4% |
| HOWARD, ZACHARY C | 1 | 63.9% | +38.2% |
| ESSEX, LAURA ANN | 1 | 59.8% | +35.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17276757 | COMBINATION THERAPIES WITH ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES | ESSEX, LAURA ANN | 46d overdue |
| 17727395 | ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | HUYNH, PHUONG N | 2d overdue |
| 18426426 | ANTIBODIES COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | HUYNH, PHUONG N | — |
| 18357956 | ANTI-CD74 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI CD74 ANTIBODY CONJUGATES AND METHODS OF USING ANTI-CD74 ANTIBODY CONJUGATES | HOWARD, ZACHARY C | — |
| Client (Assignee) | Pending OAs |
|---|---|
| SUTRO BIOPHARMA, INC. | 5 |
| Art Unit | Apps |
|---|---|
| 1641 | 2 |
| 1674 | 1 |
| 1675 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18789214 | STING AGONIST COMPOUNDS AND CONJUGATES | Sutro Biopharma, Inc. | JACKSON, SHAWQUIA | §102 | Non-Final OA | — | Pending | Jul 30, 2024 | |
| 18426426 | ANTIBODIES COMPRISING SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | Sutro Biopharma, Inc. | HUYNH, PHUONG N | 1641 | §112 | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18357956 | ANTI-CD74 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI CD74 ANTIBODY CONJUGATES AND METHODS OF USING ANTI-CD74 ANTIBODY CONJUGATES | Sutro Biopharma, Inc. | HOWARD, ZACHARY C | 1674 | §112 | Non-Final OA | — | Pending | Jul 24, 2023 |
| 17727395 | ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE | Sutro Biopharma, Inc. | HUYNH, PHUONG N | 1641 | Other | Non-Final OA | 2d overdue | Pending | Apr 22, 2022 |
| 17276757 | COMBINATION THERAPIES WITH ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES | Sutro Biopharma, Inc. | ESSEX, LAURA ANN | 1675 | §112 | Non-Final OA | 46d overdue | Pending | Mar 16, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial